Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement
- PMID: 31329288
- DOI: 10.1111/bjd.18363
Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement
Abstract
Background: Low skin-related quality of life (QoL) is usually associated with low levels of self-confidence and self-esteem and with high levels of anxiety and depression symptoms. The way patients cope with a physical disease impacts significantly on their psychosocial adjustment to the disorder and on their emotional functioning.
Objectives: To explore how coping strategies, skin-related QoL, psychological distress and self-esteem interact in a sample of individuals with neurofibromatosis type 1 (NF1).
Methods: Seventy-two adult patients with NF1 completed the following questionnaires: Coping Orientation to Problem Experiences (COPE), Skindex-29, Padua Skin-Related QoL questionnaire (PSRQ), State-Trait Anxiety Inventory-X2 form (STAI-X2), Depression Questionnaire (DQ) and Rosenberg Self-Esteem Scale (RSES). The k-modes algorithm was used to identify clusters of patients based on four variables: sex, NF1 severity, number and distribution of cutaneous neurofibromas. Individuals in different clusters were compared with regard to their scores; correlations between scores were analysed within each cluster.
Results: Two main clusters were identified: individuals in Cluster 1 had a larger number and more widespread distribution of neurofibromas compared with Cluster 2. Patients in Cluster 1 scored higher only on several PSRQ and Skindex-29 scales. Among patients in Cluster 1, the COPE 'avoidance strategies' scale was significantly correlated with the PSRQ 'physical distress and impairments' scale, the Skindex-29 'physical symptoms' and 'functioning' scales, the STAI-X2, the DQ and the RSES.
Conclusions: Patients with major skin involvement have reduced skin-related QoL. Among them, current findings tentatively suggest that the higher the use of dysfunctional coping, the more impaired are QoL, psychological distress and self-esteem. What's already known about this topic? Neurofibromatosis type 1 (NF1) can affect the quality of life (QoL) in adolescent and adult patients. Low skin-related QoL is usually associated with low levels of self-confidence and self-esteem and with high levels of anxiety and depression symptoms. Questionnaires evaluating skin-related QoL, anxiety, depression, self-esteem and coping are available. What does this study add? Patients with a large number and a widespread distribution of cutaneous neurofibromas have reduced skin-related QoL compared with patients with minor skin involvement. The newly developed Padua Skin-Related QoL questionnaire allows the simultaneous evaluation of discomfort and comfort skin-related QoL dimensions in patients with NF1. Among patients with major skin involvement, the higher the use of dysfunctional coping, the more impaired are skin-related QoL, psychological distress and self-esteem. Our data suggest that patients with NF1 with major skin involvement who endorse dysfunctional beliefs about their own coping abilities might benefit from psychological counselling and coping skills treatments aiming to both improve perceived self-efficacy and learn more adaptive coping strategies.
© 2019 British Association of Dermatologists.
Similar articles
-
The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.J Dermatol. 2024 Aug;51(8):1050-1059. doi: 10.1111/1346-8138.17276. Epub 2024 Jun 24. J Dermatol. 2024. PMID: 38923593 Free PMC article.
-
[Psycho-emotional impact of a child's disability on parents].Arch Pediatr. 2013 Jan;20(1):9-16. doi: 10.1016/j.arcped.2012.10.024. Epub 2012 Dec 20. Arch Pediatr. 2013. PMID: 23266169 French.
-
Quality of life and care burden among family caregivers of people with severe mental illness: mediating effects of self-esteem and psychological distress.BMC Psychiatry. 2022 Oct 31;22(1):672. doi: 10.1186/s12888-022-04289-0. BMC Psychiatry. 2022. PMID: 36316688 Free PMC article.
-
Quality of life and psychological impact in the photodermatoses: a systematic review.Br J Dermatol. 2020 May;182(5):1092-1102. doi: 10.1111/bjd.18326. Epub 2019 Sep 12. Br J Dermatol. 2020. PMID: 31278744 Review.
-
Measurement of the Psychological Impact of Psoriasis on Patients Receiving Systemic Treatment.Actas Dermosifiliogr (Engl Ed). 2018 Oct;109(8):733-740. doi: 10.1016/j.ad.2018.05.007. Epub 2018 Jun 30. Actas Dermosifiliogr (Engl Ed). 2018. PMID: 29970225 Review. English, Spanish.
Cited by
-
Sexual Self-Esteem and Psychological Burden of Adults With Neurofibromatosis Type 1.Front Psychol. 2022 Jun 9;13:883019. doi: 10.3389/fpsyg.2022.883019. eCollection 2022. Front Psychol. 2022. PMID: 35756263 Free PMC article.
-
Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.Children (Basel). 2024 Aug 22;11(8):1033. doi: 10.3390/children11081033. Children (Basel). 2024. PMID: 39201967 Free PMC article.
-
Self-Esteem and Coping Strategies in Adolescent Cancer Patients during the Period of Illness and Follow-Up.Eur J Investig Health Psychol Educ. 2024 Apr 24;14(5):1128-1139. doi: 10.3390/ejihpe14050074. Eur J Investig Health Psychol Educ. 2024. PMID: 38785572 Free PMC article.
-
The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.J Dermatol. 2024 Aug;51(8):1050-1059. doi: 10.1111/1346-8138.17276. Epub 2024 Jun 24. J Dermatol. 2024. PMID: 38923593 Free PMC article.
-
Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior.Children (Basel). 2023 Feb 9;10(2):330. doi: 10.3390/children10020330. Children (Basel). 2023. PMID: 36832459 Free PMC article.
References
-
- Clementi M, Barbujani G, Turolla L et al. Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 1990; 84:116-18.
-
- Ferner RE, Huson SM, Thomas N et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007; 44:81-8.
-
- Hersh JH. American Academy of Pediatrics Committee on Genetics. Health supervision for children with neurofibromatosis. Pediatrics 2008; 121:633-42.
-
- Stevenson DA, Little D, Armstrong L et al. Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium. J Pediatr Orthoped 2013; 33:269-75.
-
- Trevisson E, Cassina M, Opocher E et al. Natural history of optic pathway gliomas in a cohort of unselected patients affected by neurofibromatosis 1. J Neuro-Oncol 2017; 134:279-87.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous